📖 Approx. 3 min ／ Updated 05.07.2026
In this article, M&A advisors specializing in the medical industry will explain from a practical perspective what issues arise when transitioning to a Specified Medical Corporation in business succession and medical M&A involving patient continuity of care. We will provide specific countermeasures based on the continuity of regular patients, timing of notification, tax incentives, and public benefit requirements.
1. Industry Background of Patient Continuity of Care in the Transition to a Specified Medical Corporation
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including patient continuity of care, has become increasingly severe in recent years due to a combination of factors such as revisions to medical fees, soaring personnel costs, and the burden of capital investment. Particularly from the perspective of maintaining regular patients and the timing of notification, interest in third-party succession M&A is growing.
At the same time, the transition to a Specified Medical Corporation is an important issue in medical M&A practice. By properly designing tax incentives and public benefit requirements, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the unique operational flow, patient base, and equipment status specific to patient continuity of care, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical specialty. In patient continuity of care, the continuity of regular patients and the timing of notification are key to valuation.
- Design of Specified Medical Corporation Transition: Select the optimal scheme based on tax incentives and public benefit requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical specialty from a nationwide network. Carefully coordinate desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to patient continuity of care.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations for Patient Continuity of Care
In medical institution M&A involving patient continuity of care, the continuity of regular patients and the timing of notification are key to successful succession. There are numerous individual issues depending on the medical specialty, such as the continuity of the patient base, maintaining employment for staff (doctors, nurses, co-medical staff), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to patient continuity of care, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting patient continuity of care succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Transitioning to a Specified Medical Corporation
The transition to a Specified Medical Corporation is an area requiring specialized consideration in medical M&A. Design based on tax incentives and public benefit requirements is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys
- Risk Assessment: Identification of potential risks and formulation of countermeasures
- Consensus Building Between Parties: Designing conditions that satisfy both the transferor and the transferee
- Proper Documentation: Clear specification in the basic agreement and final contract
Frequently Asked Questions
Q. What documents are required for a consultation?
A. It would be helpful if you could prepare the financial statements for the past three fiscal years, patient number trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after the NDA is signed.
Q. What is the market price range for patient continuity of care transfers?
A. For patient continuity of care, the continuity of regular patients and the timing of notification are key valuation factors. For clinics without beds, the guideline is 0.5 to 1.5 times annual revenue, and for hospitals with beds, it’s 3 to 7 times EBITDA. We will provide details in a free preliminary assessment.
Q. What are the points to note when proceeding with the transition to a Specified Medical Corporation?
A. Prior design based on tax incentives and public benefit requirements is essential. Seamless execution of practical matters through expert collaboration is key to success.
Q. Will staff and patients be informed of the consultation?
A. Information disclosure will be limited after the NDA is signed, and no disclosure to stakeholders will be made before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Business Succession for Hospitals and Medical Corporations | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Clinic Sale & Transfer | Medical M&A Experts Explain Price Trends, Process, and Key Considerations
- How to Proceed with Medical M&A and Hospital Succession | Explaining the 6 Steps from Consultation to Agreement with Case Studies
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and Certified Public Accountants
For consultations on Patient Continuity of Care and Transition to a Specified Medical Corporation, contact M&A Medical.
Strict Confidentiality – Free Initial Consultation – Success-Based Fee